Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-11

FDA Approved: GLIPIZIDE — Supplemental Application (Northstar Rx LLC.)

View source ↗

Summary

FDA approved a supplemental application for glipizide submitted by Northstar Rx LLC, granting a new approval for this generic diabetes medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)